14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols(St. Jude Children's Research Hospital), Dario R. Alessi(MRC Protein Phosphorylation and Ubiquitylation Unit)
Cited by 402
Related Papers
Mechanism of activation of protein kinase B by insulin and IGF‐1.
|The EMBO Journal|1996|3k
Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities
|Biochemical Journal|2000|518
The PI3K‒PDK1 connection: more than just a road to PKB
|Biochemical Journal|2000|501
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
|The EMBO Journal|2017|367
Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
|Nature Communications|2014|339